Lord Maurice Saatchi

Clinical evidence revisited

May 18, 2014
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Les Rose, Lord Saatchi, Medical Innovation Bill, clinical trials

One of the most important words in the English language is ‘evidence’. It has had a seismic effect on the …

FDA logo

Heartbreak for Novartis as FDA rejects drug

May 18, 2014
Research and Development, Sales and Marketing GSK, Novartis, heart drug

Novartis has been delivered a blow by the US Food and Drug Administration as the regulator says it needs further …

AstraZeneca's Cambridge Biomedical campus

AstraZeneca signs UK research deal

May 16, 2014
Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Cambridge, Pfizer

The UK’s Medical Research Council (MRC) Laboratory of Molecular Biology (LMB) and AstraZeneca will join forces to help discover new …

roche_logo_shadow_7

Roche gets oncology boost with cancer vaccine

May 16, 2014
Research and Development, Sales and Marketing ASCO, Roche, bladder cancer, oncology

Roche’s most advanced experimental cancer immunotherapy has had impressive results in a small Phase I trial, reducing tumour size in …

boehringer_angle_22

Giotrif increases lung cancer survival

May 16, 2014
Research and Development, Sales and Marketing Boehringer, Iressa, Roche, Tarceva, afatinib, giotrif, lung cancer

Boehringer Ingelheim is trumpeting overall survival results from a new analysis of two late-stage studies involving Giotrif in lung cancer …

ASCO 2014: Cancer immune therapy race heats up

May 15, 2014
2014, ASCO, AZ, BMS, Cancer, Merck, Roche, chicago

A number of major players in oncology are set to showcase rival immunotherapy data at this year’s American Society of …

AZ image

AstraZeneca lung cancer data reveals promise

May 15, 2014
Sales and Marketing ASCO, AstraZeneca, NSCLC, azd0291, lung cancer

AstraZeneca has released promising data in a lung cancer trial with one of its investigational drugs, AZD9291, which has breakthrough …

prescription image

Scrap ‘iniquitous and outdated’ NHS prescription charges

May 15, 2014
Sales and Marketing BMJ, NHS, charges, dab, drugs, prescription

The NHS prescription charge is iniquitous and outdated and needs to be scrapped, according to an editorial in the Drug …

paul-williams600xx400-600-49-0

K-V Pharmaceutical hires head of women’s healthcare

May 15, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing KV, paul williams

K-V Pharmaceutical (KV) has hired industry veteran and former Actavis head Paul Williams to lead its women’s healthcare division.  Williams …

Medimmune image

MedImmune signs Incyte oncology deal

May 15, 2014
Research and Development, Sales and Marketing AstraZeneca, Cancer, Incyte, MedImmune, oncology

MedImmune, the global biologics R&D arm of AstraZeneca, is to put one of its oncology immunotherapies into development in combination …

Willetts image

Pfizer: ‘fewer scientists’ after merger

May 14, 2014
Research and Development, Sales and Marketing AstraZeneca, Pfizer, Read, Soriot, UK, Willetts, merger, takeover

Pfizer’s proposed takeover of AstraZeneca would result in there being fewer scientists from both companies in the UK than currently …

GSK image

More late-stage anguish for GSK heart drug

May 14, 2014
Research and Development, Sales and Marketing GSK, Patrick Vallance, darapladib, heart

GlaxoSmithKline’s experimental heart drug darapladib has failed to meet its primary endpoint in a Phase III trial for the second …

GSK image

GSK China head arrested over bribery charges

May 14, 2014
Medical Communications, Sales and Marketing China, GSK, bribery, pharma, reilly

A British man who headed-up GlaxoSmithKline’s troubled China business has been charged with two other executives on charges of bribery …

Pfizer image

Pfizer grilled by MPs – but AZ revelations shock

May 14, 2014
Medical Communications, Sales and Marketing AZ, Pfizer, committee, merger, takeover

The two chiefs of AstraZeneca and Pfizer went head-to-head with MPs yesterday fighting their own corners in what is an …

daniel_prideaux_2

Just:: appoints digital specialist

May 14, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Daniel Prideaux, Just, Just::, digital

Just:: Health Communications has hired Daniel Prideaux to head-up its digital offering.  Prideaux joins from DigitasLBi and previously worked at …

Zytiga image

NICE: no early Zytiga use

May 14, 2014
Sales and Marketing Cancer, Janssen, NHS, NICE, Zytiga, johnson, prostate

Janssen has criticised NICE’s decision not to recommend Zytiga on the NHS at an earlier stage in the prostate cancer …

Toshiba image

Toshiba creates disease diagnosis tool

May 13, 2014
Medical Communications, Research and Development, Sales and Marketing Disease, Japan, breath analyser, toshiba

Japan’s multinational electronics firm Toshiba has developed a breath-analysing prototype system that it says can be used to diagnose diseases.  …

Teva image

Teva considers up to 27 plant closures

May 13, 2014
Manufacturing and Production, Sales and Marketing Copaxone, Nerventra, Teva, cuts, generics

Teva is to close 11 of its production sites, with another 16 facilities ‘under evaluation’, as part of a major …

Allergan image

Valeant ‘substantially undervalues’ Allergan

May 13, 2014
Sales and Marketing Allergan, Botox, Pfizer, Valeant, buyout, merger

Allergan’s board has issued a defiant, unanimous rejection of the multi-billion dollar takeover offer made public by Valeant last month. In …

Ranbaxy image

Ranbaxy woes hit profits

May 13, 2014
Manufacturing and Production, Sales and Marketing Q1, Ranbaxy, Sun Pharma, manufacturing, recall

Indian generics maker Ranbaxy Laboratories has slipped up in the first quarter of the year, with profit sliding to 0.3 …

The Gateway to Local Adoption Series

Latest content